Floatz logo

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A

Malignant Mesothelioma

Roswell Park Cancer InstituteSmall moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Malignant Mesothelioma cohort.

Asset / SponsorPhaseRating
Inno-206
Mayo Clinic
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Dr Jean Yannis PERENTES
Phase 2BB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 2BB
Sargramostim
Memorial Sloan Kettering Cancer Center
Phase 2BB
FLUTICASONE
Memorial Sloan Kettering Cancer Center
Phase 2BB

View all 31 →

Same molecule, other indications

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A is also rated in:

Liver NeoplasmsDormant
B
Indicative ·
62 / 100
View asset →
Stage II Pancreatic Cancer AJCC v8Dormant
B
Indicative ·
59 / 100
View asset →
Liver MetastasisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →